{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(4)"],"submitter":["Pettifor A"],"pubmed_abstract":["<h4>Background</h4>Early in the pandemic, transmission risk from asymptomatic infection was unclear, making it imperative to monitor infection in workplace settings. Further, data on SARS-CoV-2 seroprevalence within university populations has been limited.<h4>Methods</h4>We performed a longitudinal study of University research employees on campus July-December 2020. We conducted questionnaires on COVID-19 risk factors, RT-PCR testing, and SARS-CoV-2 serology using an in-house spike RBD assay, laboratory-based Spike NTD assay, and standard nucleocapsid platform assay. We estimated prevalence and cumulative incidence of seroconversion with 95% confidence intervals using the inverse of the Kaplan-Meier estimator.<h4>Results</h4>910 individuals were included in this analysis. At baseline, 6.2%"],"journal":["PloS one"],"pagination":["e0267353"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9037948"],"repository":["biostudies-literature"],"pubmed_title":["A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic."],"pmcid":["PMC9037948"],"pubmed_authors":["Maile R","Jadi R","Kuczynski K","Wallet S","Dittmer D","Sena AC","Tan J","de Silva AM","Jones CD","Aiello A","Premkumar L","Kim M","Shook-Sa BE","Pluta L","DiPrete BL","Pettifor A","Weber DJ"],"additional_accession":[]},"is_claimable":false,"name":"A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic.","description":"<h4>Background</h4>Early in the pandemic, transmission risk from asymptomatic infection was unclear, making it imperative to monitor infection in workplace settings. Further, data on SARS-CoV-2 seroprevalence within university populations has been limited.<h4>Methods</h4>We performed a longitudinal study of University research employees on campus July-December 2020. We conducted questionnaires on COVID-19 risk factors, RT-PCR testing, and SARS-CoV-2 serology using an in-house spike RBD assay, laboratory-based Spike NTD assay, and standard nucleocapsid platform assay. We estimated prevalence and cumulative incidence of seroconversion with 95% confidence intervals using the inverse of the Kaplan-Meier estimator.<h4>Results</h4>910 individuals were included in this analysis. At baseline, 6.2%","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-06-01T00:38:06.33Z","creation":"2024-11-13T07:38:23.348Z"},"accession":"S-EPMC9037948","cross_references":{"pubmed":["35468150"],"doi":["10.1371/journal.pone.0267353"]}}